Article info

Download PDFPDF

Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C
Free
  1. Correspondence to:
    Dr J B Wong, Tufts-New England Medical Center, 750 Washington St, Box 302, Boston, MA 02111, USA;
    jwong{at}lifespan.org
View Full Text

Citation

Siebert U, Sroczynski G, Rossol S, et al
Cost effectiveness of peginterferon α-2b plus ribavirin versus interferon α-2b plus ribavirin for initial treatment of chronic hepatitis C

Publication history

  • Accepted September 3, 2002
  • First published March 1, 2003.
Online issue publication 
March 01, 2003

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.